French drugmaker MedinCell (OTC:MDCLF) announced Tuesday a partnership with AbbVie (NYSE:ABBV) to co-develop and commercialize long-acting injectables in a deal worth up to $1.9B. Per the terms, the ...
Source LinkFrench drugmaker MedinCell (OTC:MDCLF) announced Tuesday a partnership with AbbVie (NYSE:ABBV) to co-develop and commercialize long-acting injectables in a deal worth up to $1.9B. Per the terms, the ...
Source Link
Comments